• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

偏头痛致残情况:慢性偏头痛流行病学和结局-国际研究(CaMEO-I)的多国结果。

Disability in migraine: Multicountry results from the Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) Study.

机构信息

Department of Neurology, Christian Hospital Unna, Unna, Germany.

Department of Neurology, University of Duisburg-Essen, Essen, Germany.

出版信息

Cephalalgia. 2024 Aug;44(8):3331024241274343. doi: 10.1177/03331024241274343.

DOI:10.1177/03331024241274343
PMID:39175365
Abstract

BACKGROUND

Few studies of migraine have evaluated migraine disability across multiple countries using the same methodology.

METHODS

This cross-sectional, web-based survey was conducted in 2021-2022 in Canada, France, Germany, Japan, UK and USA. Respondents with migraine were identified based on modified International Classification of Headache Disorders, 3rd edition, criteria. Headache features (Migraine Symptom Severity Score (MSSS, range: 0-21), presence of allodynia (Allodynia Symptom Checklist, ASC-12)) and migraine burden (Patient Health Questionnaire-4 (PHQ-4), Migraine-Specific Quality of Life questionnaire version 2.1 (MSQ v2.1), Work Productivity and Activity Impairment (WPAI) questionnaire) were evaluated.

RESULTS

Among 14,492 respondents with migraine across countries, the mean ± SD MSSS was 15.4 ± 3.2 and 48.5% (7026/14,492) of respondents had allodynia based on ASC-12. Of all respondents living with migraine, 35.5% (5146/14,492) reported moderate to severe anxiety and/or depression symptoms. Mean ± SD MSQ v2.1 Role Function-Restrictive, Role Function-Preventive and Emotional Function domain scores were 60.7 ± 22.9, 71.5 ± 23.0 and 65.1 ± 27.2, respectively. The WPAI mean ± SD percentages of respondents who missed work or worked impaired as a result of migraine were 6.8 ± 18.1% and 41.0 ± 30.1%, respectively.

CONCLUSIONS

For every country surveyed, migraine was associated with high levels of symptom severity, with allodynia and with substantial burden.

摘要

背景

很少有研究使用相同的方法评估多个国家的偏头痛致残情况。

方法

本横断面、基于网络的研究于 2021 年至 2022 年在加拿大、法国、德国、日本、英国和美国进行。基于修改后的国际头痛疾病分类第 3 版标准,通过网络调查识别偏头痛患者。评估头痛特征(偏头痛症状严重程度评分(MSSS,范围:0-21)、痛觉过敏的存在(痛觉过敏症状检查表,ASC-12))和偏头痛负担(患者健康问卷-4(PHQ-4)、偏头痛特异性生活质量问卷 2.1 版(MSQ v2.1)、工作生产力和活动障碍(WPAI)问卷)。

结果

在各国 14492 名偏头痛患者中,平均±标准差 MSSS 为 15.4±3.2,根据 ASC-12,48.5%(7026/14492)的患者存在痛觉过敏。在所有患有偏头痛的患者中,35.5%(5146/14492)报告存在中度至重度焦虑和/或抑郁症状。平均±标准差 MSQ v2.1 角色功能受限、角色功能预防和情感功能域得分分别为 60.7±22.9、71.5±23.0 和 65.1±27.2。由于偏头痛,WPAI 平均±标准差有 6.8±18.1%和 41.0±30.1%的患者缺勤或工作效率降低。

结论

在所调查的每个国家,偏头痛均与高严重程度、痛觉过敏和大量负担有关。

相似文献

1
Disability in migraine: Multicountry results from the Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) Study.偏头痛致残情况:慢性偏头痛流行病学和结局-国际研究(CaMEO-I)的多国结果。
Cephalalgia. 2024 Aug;44(8):3331024241274343. doi: 10.1177/03331024241274343.
2
Characterizing neck pain during headache among people with migraine: Multicountry results from the Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) cross-sectional study.描述偏头痛患者头痛期间的颈部疼痛特征:国际慢性偏头痛流行病学和结局研究(CaMEO-I)的多国横断面研究结果。
Headache. 2024 Jul-Aug;64(7):750-763. doi: 10.1111/head.14753. Epub 2024 Jun 22.
3
Pre- and post-headache phases of migraine: multi-country results from the CaMEO - International Study.偏头痛的头痛前和头痛后阶段:CaMEO-国际研究的多国家结果。
J Headache Pain. 2023 Nov 8;24(1):151. doi: 10.1186/s10194-023-01683-1.
4
Characterizing gaps in the preventive pharmacologic treatment of migraine: Multi-country results from the CaMEO-I study.描述偏头痛预防性药物治疗中的差距:来自 CaMEO-I 研究的多国结果。
Headache. 2024 May;64(5):469-481. doi: 10.1111/head.14721. Epub 2024 May 5.
5
Validating Migraine-Specific Quality of Life Questionnaire v2.1 in episodic and chronic migraine.验证偏头痛特异性生活质量问卷 v2.1 在发作性和慢性偏头痛中的适用性。
Headache. 2012 Mar;52(3):409-21. doi: 10.1111/j.1526-4610.2011.01997.x. Epub 2011 Sep 19.
6
Characterizing barriers to care in migraine: multicountry results from the Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) study.分析偏头痛患者就诊障碍的特征:来自慢性偏头痛流行病学和结果-国际(CaMEO-I)研究的多国结果。
J Headache Pain. 2024 Aug 19;25(1):134. doi: 10.1186/s10194-024-01834-y.
7
A Comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: Demographics and Headache-Related Disability.慢性偏头痛流行病学与转归(CaMEO)研究和美国偏头痛患病率与预防(AMPP)研究的比较:人口统计学和头痛相关残疾情况
Headache. 2016 Sep;56(8):1280-9. doi: 10.1111/head.12878. Epub 2016 Jun 28.
8
Impact of monthly headache days on migraine-related quality of life: Results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) study.每月头痛天数对偏头痛相关生活质量的影响:慢性偏头痛流行病学和结局(CaMEO)研究结果。
Headache. 2023 Nov-Dec;63(10):1448-1457. doi: 10.1111/head.14629. Epub 2023 Oct 5.
9
Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and care.慢性偏头痛的流行病学和结局 - 国际(CaMEO-I)研究:多国家诊断率和治疗的方法和基线结果。
Cephalalgia. 2023 Jun;43(6):3331024231180611. doi: 10.1177/03331024231180611.
10
Discontinuation of Acute Prescription Medication for Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.急性偏头痛处方药停药:慢性偏头痛流行病学和结果(CaMEO)研究的结果。
Headache. 2019 Nov;59(10):1762-1772. doi: 10.1111/head.13642. Epub 2019 Sep 22.